The Effect On Self-Care and Self-Efficacy of Inhaler Training in COPD

Not Applicable

Completed

• Conditions: COPD
• Interventions: Other: Training

• Registration Number: NCT04052906
• Lead Sponsor: Nevsehir Haci Bektas Veli University

Brief Summary

This study aims to evaluate the effect of planned inhaler medication training on self-care agency and self-efficacy level.

Detailed Description

Pulmonary diseases are a major source of mortality and morbidity globally. The major symptom of COPD is dyspnea. Since dyspnea leads to activity limitation and inadequate self-care skills among individuals, it is often associated with major psychological comorbidity, social isolation and poor perceived quality of life. COPD patients with high self-efficacy are high enough to level of treatment adherence. On the other hand, the most preferred treatment method for the management and mitigation of COPD symptoms is by the use of inhaler medication. However, incorrect use of the inhaler would lead to failure in the control of COPD patients. Also, it fails to provide COPD patients with self-care agency and self-efficacy levels. In COPD, planned inhaler medication training has been shown in many studies to reduce dyspnoea, increase self-care and self-efficacy levels. Therefore, planned inhaler medication training increases quality of life in COPD patients.

Study Timeline

• Study Start: 2017-11-01
• Primary Completion: 2018-02-01
• Study Completion: 2018-05-01
• Study First Submitted: 2019-08-07
• Study First Submitted QC: 2019-08-08
• Study First Posted: 2019-08-12
• Status Verified: 2019-11
• Last Update Submitted: 2019-11-04
• Last Update Posted: 2019-11-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 67

Inclusion Criteria

• Subjects who are literate,
• Diagnosed with COPD at least six months ago,
• Using inhaler medication since three or more months,
• Moderate or severe COPD, according to GOLD criteria,
• Incorrect use inhaler medication uses according to the list of inhaler medication use skills,
• No communication problems,
• No mental confusion or any psychiatric problem,
• Agrees to participate in the study.

Exclusion Criteria

• Cognitive dysfunction,
• Severe pulmonary, cardiological or malignant disease,
• In a period of exacerbation,
• Correctly performs all steps for their prescribed inhaler medication(s), according to the list of inhaler skills.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention Group	Training	Planned Inhaler Medication Training

Primary Outcome Measures

Name	Time	Method
Self-Care Agency Scale	baseline to the 3 months after intervention	The Self-care Agency Scale (1979) was developed by Kearney and Fleischer, and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. With this scale consisting of 35 items, patients evaluate their ability or agency to perform self-care actions.
COPD Self-Efficacy Scale (CSES)	baseline to the 3 months after intervention	CSES developed by Wigal et al. (1991) is used to determine the degree of confidence that COPD patients have in managing or avoiding breathing difficulty during certain activities. The scale consists of 34 items and 5 subscales.

Secondary Outcome Measures

Name	Time	Method
Medical Research Council (MRC) Dyspnea Scale	baseline to the 3 months after intervention	The dyspnea scale is a 1 to 5 score scale consisting of five items based on various physical activities that produce a feeling of dyspnea.
Modified Borg Dyspnea Scale	baseline to the 3 months after intervention	While the Modified Borg Scale is nowadays generally used to define the severity of dyspnea in exercise, it can also be used to assess the severity of resting dyspnea

Trial Locations

Locations (1)

Gamze Muz; 🇹🇷 Nevşehir, Turkey